Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Litorina V and the JOHBECO Group in connection with the acquisition of Arvo Kokkonen Oy
Mandate

Vinge advises Litorina V and the JOHBECO Group in connection with the acquisition of Arvo Kokkonen Oy

September 30, 2019 M&A

Arvo Kokkonen Oy is a leading Finnish distributor of fresh produce with a focus on fish and shellfish.

The Swedish fresh produce group JOHBECO, consisting of, among others, Johan i Hallen and Bergfalk & Co, has strengthened its position in Finland through the acquisition of the Finnish fish and shellfish specialist Arvo Kokkonen Oy. Thanks to the partnership, Arvo Kokkonen can now offer its customers in Finland a full range of high quality fresh produce, including meat and charcuterie.

Vinge’s team consisted of partners Jonas Johansson and Matthias Pannier together with, among others, associates Carl Sander and Vilhelm Rondahl (M&A). Partner Louise Brorsson Salomon and associate Lionardo Ojeda advised on financing.

Related

Vinge advises Egetis Therapeutics in connection with ANI Pharmaceuticals’ public cash offer

 On 5 November 2026, ANI Pharmaceuticals, Inc., a U.S. biopharmaceutical company listed on The Nasdaq Global Market, announced a recommended public cash offer to the shareholders of Egetis Therapeutics AB (publ) and to the holder of Egetis’ convertible loan and warrants to tender all shares, the convertible loan and the warrants in Egetis to ANI. The total value of the offer amounts to approximately SEK 5,304 million.
November 10, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

 Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 90 million before transaction costs, with an over-allotment issue of approximately SEK 72 million.
November 09, 2026

Vinge advises SenzaGen on its acquisition of Alcyomics

 SenzaGen AB (publ) has acquired Alcyomics Ltd. The transaction is being financed through a combination of existing cash and a directed issue of convertible bonds.
November 09, 2026